Status:
COMPLETED
Neuromuscular Blocking Agents in Cardiac Surgery
Lead Sponsor:
Erasme University Hospital
Conditions:
Cardiac Surgery
Neuromuscular Blocking Agents
Eligibility:
All Genders
18+ years
Brief Summary
1. Background: Neuromuscular blocking agents (NMBA) are commonly used in cardiac surgery anesthesia to facilitate airway management and ventilation, and ensure optimal operative conditions. To imp...
Eligibility Criteria
Inclusion
- Patients aged 18 and over
- Patients scheduled for cardiac surgery using a neuromuscular blocker
- Written informed consent
Exclusion
- Absence of consent
- Minor patients
Key Trial Info
Start Date :
November 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2025
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06595277
Start Date
November 5 2024
End Date
May 15 2025
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H.U.B - Hôpital Erasme
Brussels, Belgium, 1070